InsidersTradesSigma
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Explore the full record of transactions filed by Rivard Paul, Directeur Exécutif. Officer active across 1 company, notably MyMD Pharmaceuticals, Inc.. Cumulatively, 4 disclosures have been published. Split: 4 buys · 0 sell. Total volume traded: €275k. Activity tracked since 23 November 2021. The latest transaction was filed on 24 August 2023 (Acquisition). Regulator: SEC (Form 4). The full history is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
4 条申报中的 4 条
Paul Rivard is Executive Vice President of Operations and General Counsel at MyMD Pharmaceuticals, Inc. He oversees the operations and legal matters of the company, bringing his expertise in management and law.